SureTrader
Home > Boards > Free Zone > User's Groups >

ImmunoTrend

RSS Feed
      Hide Sticky   Hide Intro
Moderator: No Moderator Assistants: Habitual
Search This Board: 
Last Post: 6/21/2016 11:32:35 PM - Followers: 1 - Board type: Free - Posts Today: 0

immunotrend will explore the many new therapies being developed for the understanding of the biology that controls both disease and lifespan.
SureTrader
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#10   http://www.onclive.com/web-exclusives/emerging-immunotherapy-target-in-spotlight Habitual 06/21/16 11:32:35 PM
#9   http://www.news-medical.net/news/20150530/Inhibitors-BGB324-and-BGB10C9-show-pro Habitual 06/14/15 10:11:24 PM
#8   Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Habitual 06/14/15 10:00:03 PM
#7   Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Habitual 06/14/15 09:59:08 PM
#6   Necrotic Cells Actively Attract Phagocytes through the Collaborative Habitual 06/14/15 09:50:25 PM
#5   Unquenchable Surface Potential Dramatically Enhances Cu(2+) Binding to Habitual 06/14/15 09:48:40 PM
#4   FDA Approves First Immunotherapy for Children With Cancer Habitual 03/19/15 10:20:44 AM
#3   Non-small cell lung cancer (NSCLC) is characterized by Habitual 03/19/15 09:03:10 AM
#2   Curis will be developing small-molecule compounds that can Habitual 01/23/15 05:38:32 PM
#1   This board was started to advance discussions regarding Habitual 09/23/14 06:15:09 PM
PostSubject